AI data centers are expanding beyond traditional land-based locations due to increasing power and space constraints. Companies like Aikido Technologies are exploring floating data centers powered by offshore wind, while Elon Musk's SpaceX plans to deploy AI data centers in orbit, powered by solar energy. These innovations aim to overcome challenges like land scarcity, energy demands, and cooling needs, though they face new technical hurdles such as saltwater corrosion and space radiation. The need for reliable data connections remains critical, with Musk's network infrastructure playing a key role in linking these new AI hubs.
AI data centers expanding beyond Earth offer context for Pluang's Technology sector, where of 150 US stocks priced, 45 rose and 104 fell as of Nov 03, 2026 06:51 WIB. Notable movers include KLTR at USD 1.56 with a +7.59% change and balanced 50% Sell / 50% Buy order activity, UMC at USD 16.68 down -7.54% but with 99% Buy orders, and AEHR at USD 59.00 up +7.45% with 89% Buy orders. This snapshot captures a mixed market mood amid innovation in AI infrastructure.
The Geely E2 (EX2) electric car has reached one million units sold globally within two years of its launch in October 2024, marking rapid market acceptance. It became the world's best-selling car in A&B segments in 2025 and topped sales charts in cou...
Global Indemnity Group will postpone its third quarter 2026 earnings call originally scheduled for November 4 to January, when new CEO Jessica Buss will present her vision and priorities for the company. The company will still release its Q3 results ...
Lorraine Ben, former CEO of Lockheed Martin Canada, has joined Syntax Defence to provide expert counsel amid Canada's commitment to invest over half a trillion dollars in defence over the next decade. This includes $180 billion in procurement opportu...
Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...
Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...
